Evidence map›Paper›PMID 40698962›Full record

ArticleApplied and environmental microbiology2025

A novel and validated 3D-printed method for the consistent and reproducible dry transfer of microorganisms for the determination of antimicrobial surface efficacy.

Emma Chareyre, Alexander J Cunliffe, Peter Askew, Gillian Iredale, Abby Marchant, Andrew P Dean, James Redfern

Abstract read
In one paragraph

Article in Applied and environmental microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emma ChareyreDepartment of Natural Sciences, Manchester Metropolitan University, Manchester, United Kingdom.ORCID 0009-0001-0958-0182
Alexander J CunliffeDepartment of Natural Sciences, Manchester Metropolitan University, Manchester, United Kingdom.ORCID 0000-0002-7099-0121
Peter AskewIndustrial Microbiological Services Ltd, Hartley Whitney, United Kingdom.
Gillian IredaleIndustrial Microbiological Services Ltd, Hartley Whitney, United Kingdom.
Abby MarchantIndustrial Microbiological Services Ltd, Hartley Whitney, United Kingdom.
Andrew P DeanDepartment of Natural Sciences, Manchester Metropolitan University, Manchester, United Kingdom.ORCID 0000-0001-6893-5118
James RedfernDepartment of Natural Sciences, Manchester Metropolitan University, Manchester, United Kingdom.ORCID 0000-0003-0958-683X

Funding

European Commission (Horizon Europe Framework Programme) 101058554UK Research and Innovation (UKRI) 10042534UK Research and Innovation (UKRI) 10055606
6 · The paper itself

Abstract

Transfer of microorganisms by touch is one way microorganisms can move within an environment. Antibacterial materials offer a potential solution, but currently, methods that use a dry inoculum, which are, therefore, realistic to many examples of touch transfer, are lacking. This study developed a novel, reproducible method for dry transfer of bacteria, using novel 3D-printed apparatuses, and applied the method to antibacterial copper surfaces. Method validation was carried out by transferring MRSA to stainless steel coupons under varying parameters and conditions (bacterial concentration, donor surface water content, bacterial inoculum drying time on donor surface). Additionally, the method was used to quantify the bacterial transfer to copper coupons under varying relative humidity environments, while comparing to the widely adopted standard ISO22196. The method demonstrated reproducible transfer of MRSA to both stainless steel and copper coupons. Antibacterial efficacy of copper following dry deposition was reduced in drier relative humidity environments, with the greatest population reduction after 2 h observed at higher relative humidity environments (>60%, 2.32-log), compared to the mid (40%-60%, 1.29-log) and low (<30%, 0.66-log) relative humidity environments. In contrast, copper demonstrated significant antibacterial activity under ISO 22196 methodology (i.e., wet inoculum and humid). These results provide a validated, novel protocol for dry transfer of bacteria for antibacterial efficacy assessment and highlight that copper-containing surfaces require greater environmental moisture for enhanced antibacterial effects. This study demonstrates the need for new standards more analogous to the end-use of an antibacterial material.IMPORTANCEThe transmission of microorganisms between surfaces by touch contributes to an increased healthcare burden due to secondary infection and mortality rates. Antibacterial materials can help to reduce the transmission of bacteria between surfaces and form part of a wider infection control system. However, testing the efficacy of antibacterial materials often uses unrealistic conditions (e.g., using large volumes of liquid) that may provide data overemphasizing their antibacterial action when in use. Additionally, there is no current standard method for assessing antibacterial surfaces contaminated via touch. This paper describes and validates a novel method to reproducibly transfer microorganisms to a surface enabling realistic deposition. Furthermore, the validated method was applied to antibacterial copper surfaces that are capable of passing current standards due to the availability of liquid (that copper surfaces require to be antibacterial) and found a reduced antibacterial effect under more realistic conditions.

Indexed as

Anti-Bacterial AgentsMethicillin-Resistant Staphylococcus aureusPrinting, Three-DimensionalCopperHumidityStainless SteelSurface PropertiesAnti-Bacterial AgentsCopperStainless Steelantibacterial materialscopperMRSAnon-submerged inoculumtouch transfer

Identifiers

PMID40698962
PMCPMC12366365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.